Bae SH - Search Results

1

Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study.

Han JW, Sung PS, Yoo JS, Cho HS, Lee SK, Yang H, Kim JH, Nam H, Lee HL, Kim HY, Lee SW, Song DS, Song MJ, Kwon JH, Kim CW, Bae SH, Jang JW, Choi JY, Yoon SK. Han JW, et al. Among authors: bae sh. Front Oncol. 2024 Feb 28;14:1372007. doi: 10.3389/fonc.2024.1372007. eCollection 2024. Front Oncol. 2024. PMID: 38482199 Free PMC article.

2

Early development of de novo hepatocellular carcinoma after direct-acting agent therapy: Comparison with pegylated interferon-based therapy in chronic hepatitis C patients.

Yoo SH, Kwon JH, Nam SW, Kim HY, Kim CW, You CR, Choi SW, Cho SH, Han JY, Song DS, Chang UI, Yang JM, Lee HL, Lee SW, Han NI, Kim SH, Song MJ, Hwang S, Sung PS, Jang JW, Bae SH, Choi JY, Yoon SK. Yoo SH, et al. Among authors: bae sh. J Viral Hepat. 2018 Oct;25(10):1189-1196. doi: 10.1111/jvh.12918. Epub 2018 May 17. J Viral Hepat. 2018. PMID: 29660199

3

Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trial.

Lee SK, Yang H, Kwon JH, Shim DJ, Kim D, Nam SW, Yoo SH, Bae SH, Lee A, Lee YJ, Jeon C, Jang JW, Sung PS, Chun HJ, Kim SH, Choi JI, Oh JS, Yang YJ. Lee SK, et al. Among authors: bae sh. Trials. 2023 Mar 28;24(1):234. doi: 10.1186/s13063-023-07266-4. Trials. 2023. PMID: 36978150 Free PMC article.

4

Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation.

Lee SK, Jang JW, Nam H, Sung PS, Bae SH, Choi JY, Yoon SK. Lee SK, et al. Among authors: bae sh. J Liver Cancer. 2020 Mar;20(1):84-89. doi: 10.17998/jlc.20.1.84. Epub 2020 Mar 31. J Liver Cancer. 2020. PMID: 37383051 Free PMC article.

5

Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of response.

Yang K, Sung PS, You YK, Kim DG, Oh JS, Chun HJ, Jang JW, Bae SH, Choi JY, Yoon SK. Yang K, et al. Among authors: bae sh. HPB (Oxford). 2019 Dec;21(12):1718-1726. doi: 10.1016/j.hpb.2019.04.017. Epub 2019 Jun 3. HPB (Oxford). 2019. PMID: 31171489 Free article.

6

The best candidates for transarterial chemotherapy in patients with hepatocellular carcinoma awaiting liver transplantation: a cohort-based characterization of dropout times.

Jang JW, Choi JY, Bae SH, Kim CW, Cho SH, Yoon SK, Yang JM, Han JY, Lee YS, Kim DG. Jang JW, et al. Among authors: bae sh. Aliment Pharmacol Ther. 2007 Jul 1;26(1):87-94. doi: 10.1111/j.1365-2036.2007.03345.x. Aliment Pharmacol Ther. 2007. PMID: 17555425 Free article.

7

Benefit of downsizing hepatocellular carcinoma in a liver transplant population.

Jang JW, You CR, Kim CW, Bae SH, Yoon SK, Yoo YK, Kim DG, Choi JY. Jang JW, et al. Among authors: bae sh. Aliment Pharmacol Ther. 2010 Feb 1;31(3):415-23. doi: 10.1111/j.1365-2036.2009.04167.x. Epub 2009 Oct 12. Aliment Pharmacol Ther. 2010. PMID: 19821808 Free article.

8

A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.

Jang JW, Lee YC, Kim MS, Lee SY, Bae SH, Choi JY, Yoon SK. Jang JW, et al. Among authors: bae sh. J Viral Hepat. 2007 Mar;14(3):169-75. doi: 10.1111/j.1365-2893.2006.00788.x. J Viral Hepat. 2007. PMID: 17305882

9

Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.

Kim JD, Choi JY, Kwon JH, Jang JW, Bae SH, Yoon SK, You YK, Kim DG. Kim JD, et al. Among authors: bae sh. Transplant Proc. 2009 Nov;41(9):3766-8. doi: 10.1016/j.transproceed.2009.10.006. Transplant Proc. 2009. PMID: 19917383

10

Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation.

Kim DS, Yoon YI, Kim BK, Choudhury A, Kulkarni A, Park JY, Kim J, Sinn DH, Joo DJ, Choi Y, Lee JH, Choi HJ, Yoon KT, Yim SY, Park CS, Kim DG, Lee HW, Choi WM, Chon YE, Kang WH, Rhu J, Lee JG, Cho Y, Sung PS, Lee HA, Kim JH, Bae SH, Yang JM, Suh KS, Al Mahtab M, Tan SS, Abbas Z, Shresta A, Alam S, Arora A, Kumar A, Rathi P, Bhavani R, Panackel C, Lee KC, Li J, Yu ML, George J, Tanwandee T, Hsieh SY, Yong CC, Rela M, Lin HC, Omata M, Sarin SK; for Asian Pacific Association for Study of Liver (APASL). Kim DS, et al. Among authors: bae sh. Hepatol Int. 2024 Apr;18(2):299-383. doi: 10.1007/s12072-023-10629-3. Epub 2024 Feb 28. Hepatol Int. 2024. PMID: 38416312

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,232 results

Search Page